Improve-IT trial

Study / Research

A trial confirming that additional ApoB lowering with ezetimibe-statin combination provides extra event reduction, even in aggressively treated patients.

Mentioned in 1 video

Videos Mentioning Improve-IT trial

#23–Tom Dayspring Part IV of V: statins, Zetia, PCSK9 inhibitors, niacin, cholesterol & the brain

#23–Tom Dayspring Part IV of V: statins, Zetia, PCSK9 inhibitors, niacin, cholesterol & the brain

Peter Attia MD

A trial confirming that additional ApoB lowering with ezetimibe-statin combination provides extra event reduction, even in aggressively treated patients.